Skip to main content

Dr Ben Shillitoe

Dr Shillitoe immunology

Dr Ben Shillitoe

Role: Consultant Paediatrician

I graduated from Newcastle University Medical School in 2009 and spent the next 13 years completing my paediatric training in the North East of England.  From 2015-2022 I worked with the Paediatric Immunology and haematopoietic stem cell transplantation (HSCT) unit at the Great North Children’s Hospital, Newcastle, one of two quaternary centres for patients with primary immune deficiencies (PID) in the UK.  Here I completed out my PhD research program and my higher specialist training.

My PhD examined the UK outcomes of patients with X-Linked agammaglobulinemia (XLA), and I continue to work on research projects for this disease, as well as other primary antibody deficiencies and the role of quality-of-life measurement tools in the management of patients with PID.

My areas of interest are improving the care of patients with PID, including both clinical and quality of life outcomes.  In addition, I am passionate about the use of registry data in the care of patients with rare diseases and sit on the UKPID registry steering committee.   I am also interested in developing links with other specialities to help detect patients with monogenic PIDs who may not initially present via the immunology service, e.g. Inflammatory Bowel Disease (IDB).

Further information on my research activity can be found at my ResearchGate profile (

    [0] => Array
            [message] => You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here:
            [code] => 453


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.